Recombinant Schistosoma mansoni 60S ribosomal protein L37a

What is the 60S ribosomal protein L37a and what is its role in Schistosoma mansoni?

The 60S ribosomal protein L37a (RPL37A) is a component of the large 60S subunit of ribosomes, which are the cellular organelles responsible for catalyzing protein synthesis. In eukaryotes including S. mansoni, ribosomes consist of a small 40S subunit and a large 60S subunit, collectively composed of 4 RNA species and approximately 80 structurally distinct proteins . In S. mansoni, as in other eukaryotes, RPL37A likely plays a crucial role in the structural integrity of the ribosome and in facilitating the translation process. The protein belongs to the L37AE family of ribosomal proteins and contains a C4-type zinc finger-like domain that may be involved in interactions with ribosomal RNA or other ribosomal proteins .

How conserved is RPL37A across different species including Schistosoma mansoni?

RPL37A demonstrates significant evolutionary conservation across eukaryotic species, reflecting its essential role in the fundamental process of protein synthesis. Sequence analysis reveals that RPL37A homologs are found in diverse organisms ranging from yeast to humans, with highly conserved functional domains . The sequence of S. mansoni RPL37A (AA 1-91) shares considerable homology with other eukaryotic RPL37A proteins . This conservation is particularly evident in the zinc finger domain, which is crucial for the protein's function.

To demonstrate this conservation, sequence comparisons can be conducted using the following methodological approach:

• Extract RPL37A sequences from various model organisms using UniProt or NCBI databases

• Perform multiple sequence alignment using tools such as MUSCLE or CLUSTALW

• Calculate sequence identity and similarity percentages

• Generate a phylogenetic tree to visualize evolutionary relationships

What structural features characterize S. mansoni 60S ribosomal protein L37a?

S. mansoni RPL37A is characterized by several key structural features that influence its function in protein synthesis:

• A C4-type zinc finger-like domain, which is critical for interactions with ribosomal RNA

• A compact structure of approximately 91 amino acids in length

• A predominantly cytoplasmic localization, consistent with its role in ribosomal assembly and protein synthesis

Methodological approach for structural analysis:

• X-ray crystallography or cryo-EM can be used to determine the three-dimensional structure

• Homology modeling based on solved structures from related species

• Circular dichroism spectroscopy to assess secondary structure composition

• Nuclear magnetic resonance (NMR) for solution structure determination

What expression systems are most effective for producing recombinant S. mansoni RPL37A?

The selection of an appropriate expression system is critical for obtaining functionally active recombinant S. mansoni RPL37A. Based on experimental evidence, several systems have proven effective:

The yeast expression system has been documented as particularly effective for producing recombinant ribosomal proteins, including RPL37A from various species, with purity levels exceeding 90% .

Methodological considerations:

• Codon optimization for the selected expression system

• Temperature optimization during induction (typically lower temperatures improve solubility)

• Selection of appropriate fusion tags to enhance solubility and facilitate purification

• Optimization of induction conditions (inducer concentration, duration)

How can researchers purify recombinant S. mansoni RPL37A while maintaining its native conformation?

Purification of recombinant S. mansoni RPL37A requires careful consideration of its structural integrity. The following methodological approach has been successful:

• Affinity chromatography: His-tagged RPL37A can be purified using Ni-NTA or cobalt-based resins

• Buffer optimization: Including zinc ions in purification buffers helps maintain the integrity of the zinc finger domain

• Gentle elution conditions: Using imidazole gradients rather than pH changes for His-tagged proteins

• Size exclusion chromatography as a polishing step to remove aggregates and contaminants

• Quality assessment using dynamic light scattering to confirm monodispersity

Critical parameters to monitor during purification:

• Temperature (maintain at 4°C throughout purification)

• Protease inhibitor inclusion to prevent degradation

• Reducing agents (such as DTT or β-mercaptoethanol) to prevent oxidation of cysteine residues

• Final buffer composition optimization for long-term stability

What are the validated methods for assessing the purity and functionality of recombinant S. mansoni RPL37A?

Multiple complementary approaches should be employed to assess both purity and functionality:

Purity Assessment:

• SDS-PAGE with Coomassie staining (>90% purity is typically achievable)

• Western blotting using anti-His antibodies for recombinant tagged protein

• Mass spectrometry to confirm protein identity and assess heterogeneity

• Capillary electrophoresis for high-resolution purity analysis

Functionality Assessment:

• RNA binding assays to assess interaction with ribosomal RNA

• Circular dichroism to confirm proper folding

• Thermal shift assays to assess structural stability

• In vitro translation assays to confirm biological activity in reconstituted systems

How does post-translational modification affect the function of S. mansoni RPL37A during host-parasite interactions?

Post-translational modifications (PTMs) of RPL37A may play significant roles in regulating its function during host-parasite interactions, though specific data on S. mansoni RPL37A modifications remains limited. Research methodologies to investigate this question include:

• Mass spectrometry-based PTM mapping:

  • Enrichment strategies for phosphorylated, acetylated, and ubiquitinated peptides

  • Comparison of PTM profiles between free-living and host-associated parasite stages

  • Temporal analysis during infection progression

• Functional analysis of identified PTMs:

  • Site-directed mutagenesis of modified residues

  • Comparative phenotypic analysis of mutants

  • In vitro reconstitution assays with modified vs. unmodified protein

Laser-capture microdissection (LCM) coupled with proteomic analysis provides a powerful approach for investigating proteins involved in host-parasite interactions, as demonstrated in studies of S. mansoni sporocysts during encapsulation by host hemocytes . This technique allows for the isolation and analysis of proteins from specific cellular contexts during infection.

What is the potential of S. mansoni RPL37A as a target for vaccine development?

The evaluation of S. mansoni RPL37A as a vaccine candidate requires a systematic approach:

• Epitope prediction and analysis:

  • In silico prediction of B-cell and T-cell epitopes

  • Conservation analysis across parasite strains

  • Assessment of cross-reactivity with host homologs

• Experimental validation:

  • Peptide array analysis to examine immunogenicity with sera from infected hosts

  • Testing of recombinant protein or epitope-based constructs in animal models

  • Evaluation of protective efficacy using challenge infections

• Adjuvant selection and formulation optimization:

  • Systematic testing of adjuvant combinations

  • Dose-response studies

  • Route of administration optimization

Reverse vaccinology approaches, as described in search result , provide a methodological framework for identifying and evaluating potential vaccine candidates from the S. mansoni genome. This involves assembly and annotation of the parasite genome sequence followed by evaluation of putative cell-surface antigen genes for their immunogenic potential.

How can researchers investigate the role of S. mansoni RPL37A in the parasite's immune evasion strategies?

Investigating the potential role of RPL37A in immune evasion requires multi-faceted experimental approaches:

• Comparative expression analysis:

  • Quantitative proteomics comparing expression levels across life cycle stages

  • Analysis of expression changes upon exposure to immune factors

  • Localization studies using immunofluorescence microscopy

• Host-parasite interaction studies:

  • Pull-down assays to identify host proteins that interact with RPL37A

  • Surface plasmon resonance to quantify binding interactions

  • Co-immunoprecipitation from infected host tissues

• Functional validation:

  • RNA interference or CRISPR-based knockdown/knockout studies

  • Transgenic parasites expressing modified forms of RPL37A

  • Ex vivo assays measuring immune cell responses to recombinant RPL37A

The proteomic analysis techniques described in search result , including laser-capture microdissection combined with nano-LC tandem mass spectrometry, provide valuable methodological approaches for studying proteins involved in host-parasite interactions.

How can researchers overcome expression challenges when working with recombinant S. mansoni RPL37A?

Researchers may encounter several challenges when expressing recombinant S. mansoni RPL37A. The following methodological approaches can address common issues:

• Addressing protein insolubility:

  • Fusion with solubility-enhancing tags (GST, MBP, SUMO)

  • Co-expression with chaperones (GroEL/GroES, DnaK/DnaJ)

  • Expression at lower temperatures (16-20°C)

  • Use of specialized E. coli strains designed for difficult proteins

• Optimizing codon usage:

  • Analysis of codon bias between S. mansoni and expression host

  • Synthesis of codon-optimized gene constructs

  • Use of hosts with rare codon tRNAs for heterologous expression

• Addressing toxicity in expression hosts:

  • Use of tightly controlled inducible promoters

  • Reduction of basal expression using glucose suppression for lac-based systems

  • Sequential induction strategies for toxic proteins

• Improving yield:

  • Optimization of media composition and supplementation

  • Fed-batch cultivation strategies

  • Design of experiments (DoE) approach to optimize multiple parameters simultaneously

What are the best practices for designing experiments to investigate RPL37A function in Schistosoma mansoni?

Experimental design for investigating RPL37A function should follow these methodological principles:

• Controls and validations:

  • Include appropriate positive and negative controls

  • Validate antibodies using western blotting against recombinant protein

  • Use multiple experimental approaches to confirm findings

• Life cycle considerations:

  • Include multiple life cycle stages in comparative analyses

  • Consider developmental timing in experimental design

  • Account for host factors in ex vivo and in vivo experiments

• Statistical design:

  • A priori power analysis to determine sample sizes

  • Account for biological and technical replicates

  • Select appropriate statistical tests based on data distribution

• System biology approaches:

  • Integrate transcriptomic, proteomic, and functional data

  • Construct protein-protein interaction networks

  • Apply pathway analysis to contextualize findings

How can researchers integrate proteomics and transcriptomics data to gain insights into S. mansoni RPL37A regulation?

Integration of multi-omics data provides comprehensive insights into RPL37A regulation and function:

• Data collection and normalization:

  • Collection of matched samples for proteomics and transcriptomics

  • Application of appropriate normalization methods for cross-platform comparisons

  • Quality control metrics to identify potential batch effects

• Correlation analysis:

  • Calculation of Pearson or Spearman correlation between mRNA and protein levels

  • Identification of post-transcriptional regulation events

  • Temporal analysis to identify delays between transcription and translation

• Regulatory network reconstruction:

  • Identification of transcription factors regulating RPL37A expression

  • Analysis of post-transcriptional regulators (miRNAs, RNA-binding proteins)

  • Integration with epigenetic data where available

• Visualization and interpretation:

  • Development of integrated visualization approaches

  • Pathway enrichment analysis

  • Comparison with other model organisms to identify conserved regulatory mechanisms

The application of multiple transcriptomes to identify protein-coding gene sequences, as mentioned in search result , provides a valuable methodological approach for integrating genomic and transcriptomic data.

What bioinformatic approaches are most effective for predicting epitopes on S. mansoni RPL37A for vaccine development?

Effective epitope prediction requires a multi-algorithm approach:

• B-cell epitope prediction:

  • Surface accessibility analysis

  • Hydrophilicity profiling

  • Antigenicity scoring using methods like Kolaskar and Tongaonkar

  • Structural prediction to identify surface-exposed regions

• T-cell epitope prediction:

  • MHC class I and II binding prediction

  • Proteasomal cleavage site prediction for class I epitopes

  • Conservation analysis across parasite strains

  • Population coverage analysis for MHC binding

• Validation and refinement:

  • Cross-validation using multiple prediction algorithms

  • Experimental validation using synthetic peptides

  • Iterative refinement based on experimental feedback

• Epitope optimization:

  • Enhancement of stability through strategic amino acid substitutions

  • Optimization of flanking residues for processing

  • Combination of multiple epitopes into chimeric constructs

The reverse vaccinology approach described in search result provides a methodological framework for identifying vaccine candidates from genomic data, which can be applied to S. mansoni RPL37A.

How can structural biology approaches advance our understanding of S. mansoni RPL37A function?

Structural biology provides critical insights into protein function and potential therapeutic targeting:

• Structure determination methods:

  • X-ray crystallography for atomic-level resolution

  • Cryo-electron microscopy for visualization within larger complexes

  • NMR spectroscopy for dynamic structural information

  • Small-angle X-ray scattering for solution structure information

• Computational approaches:

  • Homology modeling based on solved structures from related species

  • Molecular dynamics simulations to understand conformational flexibility

  • Protein-protein docking to predict interaction interfaces

  • Virtual screening for potential inhibitors

• Integration with functional data:

  • Structure-guided mutagenesis to test functional hypotheses

  • Correlation of structural features with biochemical properties

  • Mapping of evolutionary conservation onto structural models

• Translational applications:

  • Structure-based drug design targeting unique features

  • Rational design of high-affinity antibodies

  • Engineering of modified forms with enhanced stability or immunogenicity

What are the methodological considerations for studying RPL37A interactions with host immune factors?

Investigating RPL37A interactions with host immune factors requires robust methodological approaches:

• In vitro interaction studies:

  • Surface plasmon resonance for kinetic and affinity measurements

  • Enzyme-linked immunosorbent assays for qualitative binding assessment

  • Protein microarrays for high-throughput interaction screening

  • Isothermal titration calorimetry for thermodynamic characterization

• Cellular assays:

  • Flow cytometry to assess binding to immune cells

  • Immunoprecipitation from infected host tissues

  • Reporter cell assays to measure functional outcomes of interactions

  • Confocal microscopy to visualize interactions in cellular context

• Ex vivo and in vivo validation:

  • Perfusion models using host vasculature

  • Explant cultures of host tissues

  • Animal models of infection with readouts for specific immune parameters

  • Validation in samples from naturally infected hosts

• Proteomic approaches:

  • Cross-linking mass spectrometry to identify interaction interfaces

  • Hydrogen-deuterium exchange mass spectrometry to map binding sites

  • Laser-capture microdissection combined with proteomics to study context-specific interactions